Loracarbef Oral Tablets and Suspension

02 March 2007

Products Affected - Description

Lorabid, King Pharmaceuticals

Reason for the Shortage

King states that Lorabid was discontinued in September 2006 for business reasons. Some product has been available in the interim, but King is no longer accepting orders for this product. There are currently no other suppliers of loracarbef.

Estimated Resupply Dates

Loracarbef tablets and suspension are discontinued.

Related Shortages

• Aztreonam Injection
• Carbenicillin Indanyl Capsules— No Longer Available
• Cefaclor
• Cefazolin Injection— Resolved
• Cefepime Injection— Resolved
• Cefotetan Disodium— Resolved
• Cefotetan Injection— Resolved
• Cefoxitin Injection— Resolved
• Ceftizoxime Injection— Resolved
• Cefuroxime Injection— Resolved
• Ciprofloxacin Immediate-Release Tablets
• Doxycycline Hyclate Injection
• Erythromycin Lactobionate Injection
• Erythromycin Ophthalmic Ointment
• Imipenem and Cilastatin Injection— Resolved
• Kanamycin— Resolved
• Kanamycin Sulfate Injection
• Minocycline Injection— No Longer Available
• Nafcillin Injection— Resolved
• Oxacillin Injection— Resolved
• Penicillin G Benzathine Injection— Resolved
• Penicillin G Procaine Suspension for Injection— Resolved
• Piperacillin and Tazobactam Injection— Resolved
• Polymyxin B Injection— Resolved
• Ticarcillin and Clavulanate Injection— Resolved
• Tigecycline Injection— Resolved
• Tobramycin Powder for Injection
• Vancomycin Hydrochloride Injection

Updated

March 2, 2007, University of Utah, Drug Information Service

Back to Drug Shortage Product Bulletins